IP Verse

Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna

Patent No. EP4066857 (titled "Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna") was filed by Glaxosmithkline on Aug 31, 2011. The application was issued on Dec 21, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSSep 21, 2023MEWBURN ELLIS
THOMANNSep 21, 2023THOMANN
WEICKMANN & WEICKMANNSep 20, 2023WEICKMANN & WEICKMANN PARTMBB
SANOFISep 19, 2023ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4066857

GLAXOSMITHKLINE
Application Number
EP22174932A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Nov 18, 2022
Publication Date
Dec 21, 2022
External Links
Slate, Register , Google Patents